Serum Institute gets DCGI's nod to manufacture Covid vaccine Sputnik V in India: Report1 min read . Updated: 05 Jun 2021, 06:01 AM IST
- The Pune-based SII has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow in Russia for developing Sputnik V at its licensed Hadapsar facility
Days after applying to the Drug Controller General of India seeking permission to manufacture the Sputnik V coronavirus jab for examination, test and analysis, the Serum Institute of India has been granted permission by the DCGI.
Select your Category